Nxera Pharma Co (Nxera Pharma Co) EV-to-FCF : -23.11 (As of May. 01, 2024)

Nxera Pharma Co EV-to-FCF Chart

Nxera Pharma Co Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-FCF		Get a 7-Day Free Trial					48.67	26.64	18.03	14.34	-24.77

Nxera Pharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-FCF	Get a 7-Day Free Trial															14.34	14.86	8.96	4,037.87	-24.77

Competitive Comparison of Nxera Pharma Co's EV-to-FCF

For the Biotechnology subindustry, Nxera Pharma Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's EV-to-FCF falls into.

Nxera Pharma Co EV-to-FCF Calculation

Nxera Pharma Co's EV-to-FCF for today is calculated as:

Nxera Pharma Co's current Enterprise Value is $997.26 Mil.
Nxera Pharma Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-43.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co  (OTCPK:SOLTF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Nxera Pharma Co's PE Ratio for today is calculated as:

Nxera Pharma Co's share price for today is $9.3039.
Nxera Pharma Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.605.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Nxera Pharma Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description